ISPC
iSpecimen Inc.0.4084
-0.0124-2.95%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
3.99MP/E (TTM)
-Basic EPS (TTM)
-7.82Dividend Yield
0%Recent Filings
8-K
8-K
8-K
8-K
Crypto treasury update
iSpecimen Inc. updated its strategic push into digital assets on September 4, 2025, revealing approaches from cryptocurrency firms offering tokenized real-world assets and top cryptocurrencies, while advancing a Solana-based treasury program targeting up to $200 million. The company plans to buy SOL, including discounted Locked SOL, via OTC deals for staking and limited spot trading to diversify its balance sheet and fuel growth, funded by future capital raises. Yet risks loom in crypto's regulatory haze.
8-K
Milestone 1 completed in transformation
iSpecimen Inc. completed Milestone 1 of its digital transformation on August 21, 2025, installing the Salestack platform to modernize its biospecimen marketplace infrastructure. This upgrade delivers immediate gains in reliability, security, and innovation speed through automated, multi-cloud architecture. Yet challenges persist in realizing full benefits. The company now advances to Milestone 2 for deeper business integration.
BIAF
bioAffinity Technologies, Inc.
1.38-0.10
IDXG
Interpace Biosciences, Inc.
1.14-0.02
ILMN
Illumina, Inc.
131.56-3.36
IMDX
Insight Molecular Diagnostics I
5.10+0.08
IQV
IQVIA Holdings, Inc.
221.68-1.95
LH
Labcorp Holdings Inc.
258.11-5.22
NOTV
Inotiv, Inc.
0.68-0.02
PRPO
Precipio, Inc.
24.02-0.04
QGEN
Qiagen N.V.
45.01-0.43
TMO
Thermo Fisher Scientific Inc
570.16-5.75